Surface Oncology Financials

Surface Oncology Stock Summary

Surface Oncology competes with Syros Pharmaceuticals, Repare Therapeutics, Personalis, Evogene, and Iovance Biotherapeutics. Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Surface Oncology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people.

Surface Oncology Key Financial Ratios

Surface Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Surface Oncology's current stock value. Our valuation model uses many indicators to compare Surface Oncology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surface Oncology competition to find correlations between indicators driving Surface Oncology's intrinsic value. More Info.Surface Oncology is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Surface Oncology by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Surface Oncology Market Pulse

Along with financial statement analysis, the daily predictive indicators of Surface Oncology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Surface Oncology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Surface Oncology based on widely used predictive technical indicators. In general, we focus on analyzing Surface Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Surface Oncology's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

If you are still planning to invest in Surface Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surface Oncology's history and understand the potential risks before investing.